Morning, welcome to IPG Photonics Third Quarter 2020 Conference Call. Today's call is being recorded and webcast. At this time, I would like to turn the call over to Angelo Lopresti, IPG's Senior Vice President and General Counsel for introductions. Please go ahead, sir.
Thank you, operator, good morning, everyone. With us today is IPG Photonics Chairman and CEO, Dr. Valentin Gapontsev, Chief Operating Officer, Dr. Eugene Scherbakov, and Senior Vice President and CFO, Tim Mammen. Statements made during the course of this call that discuss management or the company's intentions, expectations, or predictions of the future are forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause the company's actual results to differ materially from those projected in such forward-looking statements. These risks and uncertainties include the impact of the COVID-19 pandemic on our business and those detailed in IPG Photonics Form 10-K for the period ending December 31, 2019, and other reports on file with the Securities and Exchange Commission. Copies of these filings may be obtained by visiting the investor section of IPG's website or by contacting the company directly.
You may also find copies on the SEC's website. Any forward-looking statements made on this call are the company's expectations or predictions only as of today, October 30, 2020. The company assumes no obligation to publicly release any updates or revisions to such statements. For additional details on our reported results, please refer to the earnings press release and the Excel-based financial data workbook posted to our investor relations website. We'll post these prepared remarks on our investor relations website following the completion of the call. With that, I'll now turn the call over to Valentin.
Good morning, everyone. We demonstrated excellent execution in the third quarter and delivered the result above our guidance range despite continued challenges from the COVID-19 pandemic and general economic slowdown. Our performance was driven by two factors. First, strong revenue in China, which improved slightly from a strong second quarter and increased meaningfully from the third quarter of 2019. Second, a sequential improvement in Europe, which recovered from the low point in the second quarter 2020. Economic indicators show improvement from the significant contraction in activity in the second quarter, and this helped to drive improved performance in the third quarter. Sales of high power lasers above 6 kW increased more than 15% compared to the third quarter of 2019. Revenue from other applications increased by 24%, primarily from higher revenue from advanced applications, which was driven by revenue from high power single mode fiber lasers in medical procedures.
We're demonstrating good progress in our core markets, thanks to our technology differentiation and low-cost production capabilities. In the cutting market, we delivered strong year-over-year growth in both our rack-mounted 1 kW-4 kW lasers for the high volume markets and our ultra-high power lasers for leading-edge cutting systems. Ultra-high power lasers made up more than 58% of total high power sales. Our customers are working on integrating the new ultra-compact rack-mounted U series of lasers into their low-cost cutting systems, and we expect to receive the first volume orders in the coming months. The new U series has extended optical performance with the smallest size, lowest weight in the industry, and record power to volume ratio. For the first time, this range of devices provides full protection against humidity penetration, what is extremely important in the field use.
At the high end market, we are benefiting from an increase in order volume for our 20 kW and 30 kW ultra-high power lasers and optical heads. These lasers not only enable 50%-100% faster cutting speeds than 15 kW device, but are capable of processing materials with 20 mm-50 mm of thickness or greater. This improvement in both productivity and flexibility is driving the replacement of plasma cutting machines and lower power laser solutions. This is particularly true in machine shops and construction equipment manufacturing. This laser provides superior beam parameters, record for class efficiency, and unique high reliability. They are the hallmarks of the IPG brand. They also drive a superior return on investment for our customers. Our Adjustable Mode Beam lasers continue to gain traction in the welding industry, most notably in the electric vehicle battery welding.
Our AMB products offers superior speed and weld quality, our competing solutions, thanks to the broadest range of beam tunability. This enables spotless welding. In addition, we continue to expect strong growth in our high-power nanosecond pulse lasers used for foil cutting and cleaning in electrical vehicle battery processing, as well as for ablation and cleaning in other industries. Product innovation remains core to IPG's success. During the first quarter, emerging product and application sales were 21% of total revenue, increasing 5% year-over-year, despite softer demand trend due to COVID-19 in several new product categories, including systems. Sales of medical lasers increased more than 30% year-over-year as we continue to sell our gold standard thulium laser solution and consumable fibers for urology and other soft tissue applications. Advanced applications revenue increased 50% year-over-year in Q3, driven by strengths in government and semiconductor applications.
Despite the impact of COVID-19, sales of green, ultraviolet, and ultrapulse lasers into emerging microprocessing applications show strong growth year-over-year. In addition, we have a very strong backlog of green lasers and improved backlog for UV and ultrapulse lasers as a result of orders received in the last quarter. Our green pulsed laser are enabling significant improvement in solar cell efficiency. We continue to target more than 50 new projects for these lasers across a wide range of applications. This includes processing of glass, thick glass especially, ceramics, composite materials, numerous crystals, circuit boards, OLED film, batteries, and solar cells. We are investing in a number of next generation solution with significant disruptive potential that we plan to launch over the next 6 to 12 months.
Customer evaluation of our LightWELD has been very positive. They have cited improvement in weld quality, diversity of materials that can be joined, and programmed welding parameters for different types and thickness of material as advantages. The multi-channel TCV lasers for high-speed spot welding application have the potential to be disruptive in displacing very inefficient Nd:YAG lasers. This is due to significant cost saving they can bring due to the increase in welding productivity and decrease in electrical consumption. Our kilowatt scale pulsed laser for ablation and cleaning application are also continuing to gain acceptance. Beyond material processing, we continue to develop new soft tissue medical treatments, mid-infrared lasers for molecular level resolution online spectroscopy, inspection, sensing and biomedical research applications, and new high-speed transceiver for telecom and datacom markets.
I want to conclude by thanking our employees for their strong execution during one of the most challenging period in our company's history. The diligence of our employees to keep each other safe has enabled us to return our operation back to normal within safety guidelines. Of course, the well-being of our employees, their families, our customers, our partners, and our community remains our highest priority. With that, I will send the call over to Eugene Scherbakov.
Thank you, Valentin. Good morning, everyone. I will begin by discussing the effects of COVID-19 on our production. All three of our major production facility in Germany, the U.S., and Russia remain open and operating normally, and we haven't seen any disruption of our manufacturing or our service capability in the regions where we operate. Our global facility operating on largely normalized basis, albeit with social distancing and enhanced cleaning and filtration measures in place. In addition, we were back to normal operation promptly after we reported the ransom attack in September. The incident did not have any material impact on our business operations, financial conditions, or on our ability to report financial results. As we disclosed earlier, we carry cyber insurance to cover this type of risk. Nonetheless, IPG is conducting an analysis to improve the security and resiliency of our systems.
We continue to benefit from our vertically integrated production model, which enables key technologies, technological and cost advantages for our competition while minimizing the supply chain disruption. The current constraints on our business primarily relate to restrictions on travel that affect our sales team and customer visits related to applications development. Logistics were less impacted in third quarter, and we did not encounter any meaningful disruption of our ability to ship components and finished product around the world. As a percent of sales, shipping costs were slightly lower than they were in the second quarter. We continue to benefit from reduction of the cost of devices and from expense reduction initiated, we undertook in the second half of 2019. Gross margin improved to 48% this quarter.
The total SG&A and R&D expenses increased by $2.8 million to $78 million in the third quarter, compared to the $75.3 million in the second quarter, while sales revenue increased by $22 million. Operating expenses continue to track well below the peak level of $84 million incurred in the second quarter in 2019. Examining our performance by region, revenue in China increased 22% year-over-year, representing approximately 47% of total sales. New orders booked in China were slow at the beginning of the quarter but picked up in September. China continued to have significant backlog given the exceptional level of orders booked in the first half of the year.
While we face aggressive competition in the region for lasers at 6 kW and below, we continue to maintain share at key accounts while anticipating a strong mix of laser at 10 kW or greater in the future. In Europe, revenue decreased 10% year-over-year due to the effect of COVID-19 on many countries in the region. Similarly, revenue in North America decreased 26% year-over-year, with strong growth in the medical and advanced application not being sufficient to offset declines in lasers and system sales for material processing. While North America revenue was weak in the third quarter, it was notable that order booking were exceptional and benefited from several large orders from advanced applications and for our unique green lasers used in renewable energy. Sales in Japan decreased 41% year-over-year.
While COVID-19 infections in the region are below other countries, the recurring stop and restart of economic activity has delayed many significant projects within our welding and cutting businesses in Japan. Sales to the rest of Asia increased 6% year-over-year and recovered from the second quarter through the quarter, and also benefited from shipment of high power lasers for advanced applications. Sales in Turkey increased 15% year-over-year and by more than 100% as compared to the second quarter. Global demand trends remain uncertain. We have seen continuing delay of projects globally, which makes the execution of the third quarter all the more notable.
We continue to believe that our large and diverse advanced materials and components technology platform, our efficient R&D model, and our strong balance sheet and free cash flow provide us ample flexibility to respond to business disruption and emerge from pandemic and stronger competitive position. With that, I will turn the call over to Tim to discuss financial highlights in the quarter.
Thank you, Eugene, and good morning, everyone. Revenue in the third quarter was $318 million, which declined 3% year-over-year, increased 7% quarter-over-quarter. Revenue from materials processing applications decreased 5% year-over-year, revenue from other applications increased 24%. Sales of high-power CW lasers were flat year-over-year and represented approximately 58% of total revenue. Sales of ultra-high power lasers at 6 kW or greater represented 58% of total high-power CW laser sales. Pulsed laser sales increased 3% year-over-year, with strong growth in green pulsed lasers used in solar cell manufacturing, as well as higher sales of our new UV and ultrafast pulsed lasers, which were partially offset by lower sales of lower power pulsed lasers for marking applications.
Systems sales decreased 37% year-over-year, as growth in systems for medical device manufacturing was offset by lower sales of other IPG laser systems and Genesis non-laser systems. Medium power laser sales decreased 1% on continued softness in additive manufacturing and the transition to kilowatt scale lasers in cutting. QCW laser sales increased 21% year-over-year from sequential improvement in consumer electronics applications. Other product sales increased 8% year-over-year, driven by growth in medical laser sales. Q3 gross margin was 48%, which increased 160 basis points year-over-year. Compared with the year ago period, the increase in gross margin was driven primarily by lower cost of products, which was offset by an increase in inventory provisions as compared to the year ago period. Third quarter GAAP operating income was $41 million and operating margin was 13%.
Goodwill impairment charges related to Genesis Systems Group reduced operating income by $45 million and reduced operating margin by 14 percentage points. The results of this business were impacted by lower capital investments from industries impacted greatly by the COVID-19 pandemic, such as aerospace and transportation, as projects have been delayed. We continue to be focused on numerous opportunities for Genesis, including transitioning to a higher percentage of laser-based systems, as well as expanding the international systems opportunities. We are hopeful that it will ultimately enable progress to be made on broader-based laser welding applications across many different industries. During the quarter, we recognized a foreign exchange gain of $11 million, primarily related to revaluation of U.S. dollar cash and other assets held in Russia, given the depreciation of the ruble versus the U.S. dollar, and to the appreciation of the Chinese yuan.
The foreign exchange gain increased Q3 operating margin by 350 basis points. Q3 net income was $36 million, or $0.66 per diluted share. The goodwill impairment charge reduced EPS by $0.63, while foreign exchange gains benefited EPS by $0.15. The effective tax rate in the quarter was 16%. If exchange rates relative to the U.S. dollar had been the same as one year ago, we would have expected revenue to be $4 million lower and gross profit to be $3 million lower. We ended the quarter with cash equivalents, and short-term investments of $1.3 billion and total debts of $39 million. Strong operational execution resulted in cash provided by operations of $70 million during the quarter. As a result of COVID-19, we have reduced our planned capital expenditures for the year.
Capital expenditures were $25 million in the third quarter. We now expect capital expenditures will be in the range of $80 million-$100 million for the full year. During the quarter, we repurchased 61,000 shares for $10 million. Bookings growth in North America and Europe was strong compared to the second quarter, while total orders in China were low. In North America, we had record bookings aided by several orders for advanced applications and emerging products. While total orders in China for the third quarter were lower, China continues to have a significant backlog given the exceptional level of orders booked in the first half of the year. In total, third quarter book-to-bill was slightly below one. Overall, it was also notable that order bookings improved markedly during September.
It is difficult to predict whether the improvement in some macroeconomic indicators will be sustained given the resurgence of COVID-19 in Europe and North America, and its potential impact on economic activity. These uncertainties continue to make forecasting our business challenging in the near to medium term. That said, we continue to benefit from near-term growth opportunities in ultra-high power cutting, electric vehicle battery processing, medical procedures, and advanced applications. We believe the strides we are making in higher power products within our core materials processing business and new solutions will enable us to emerge from the current downturn in a stronger competitive position. For the fourth quarter of 2020, IPG expects revenue of $290 million to $320 million. The company expects the fourth quarter tax rate to be approximately 25%.
IPG anticipates delivering earnings per diluted share in the range of $0.75 to $1.05, with 53.1 million basic common shares outstanding and 53.7 million diluted common shares outstanding. Financial guidance provided this quarter is subject to greater risk and uncertainty given the COVID-19 pandemic and its associated impacts to the global business environment, public health requirements, and government mandates. As discussed in the Safe Harbor passage of today's earnings release, actual results may differ from our guidance due to factors including, but not limited to, goodwill and other impairment charges, product demand, order cancellations and delays, competition, tariffs, trade policies, health epidemics, and general economic conditions. Our guidance is based upon current market conditions and expectations, assumes exchange rates referenced in our press release, and is subject to risks outlined in the company's reports with the SEC.
With that, Valentin, Eugene, and I will be happy to take your questions.
Thank you. At this time, we'll now be conducting a question and answer session. Due to the number of analysts joining us today, we ask you to limit yourself to one primary question and one follow-up question. If you'd like to ask a question today, please press star one from your telephone keypad, and a confirmation tone will indicate your line is in the question queue. You may press star two if you'd like to remove your question from the queue. If you're listening using speaker equipment, it may be necessary to pick up your handset before pressing the star keys. One moment, please, while we poll for questions. Thank you. Our first question is coming from the line of Jim Ricchiuti with Needham & Company. Please proceed with your questions.
Hi. Thank you. Good morning. I wanted to follow up on the comments you made about the bookings picking up in September. Can you elaborate on where you're seeing the activity and to what extent that may have been sustained thus far in October?
Jim, good morning. The phasing of orders and the tone of orders in the quarter was a bit weaker in July and August and was really exceptionally strong in September. That strength was driven, in particular, by improvements in North America and China. Overall, the order flow in Europe was a bit more even. It was actually stronger than it had been in the second quarter. The North American bookings, as we referenced, benefited from significant orders for advanced applications, some of which are scheduled to ship in Q4 and some of which are probably going to be Q1. We may be able to get some of them into the fourth quarter as well. Very strong orders for some of the emerging products, particularly green lasers, and even better orders during the quarter for slightly better orders for UV and ultrafast.
In October, the first week in October, China was actually on holiday, so there was no activity in China. Since then, particularly in the last week and a half, the overall tone of order flow has actually picked up in China. It's been quite strong in Europe since the beginning of October, which is interesting. In North America in the last four or five days, it's also improved meaningfully. We've had another order for green lasers from Southeast Asia as well. We're actually quite pleased with the general tone of order flow in the business, given the disruptions that you're seeing in the market.
Got it. Just curious, we're hearing more and more about a pickup in the automotive market. Are you seeing any signs of that in the business, including potentially in the Genesis business?
Not so much in Genesis. I think automotive, there is certainly a little bit more strength to it. It's difficult to bifurcate it between traditional EV. There's a lot of investment going on in EV, and that's not just happening in China. There's significant orders we're waiting for in North America as well for this. There's an order we just took this week for EV. I'd say that the order flow in Europe around automotive is still a little bit weaker. There's certainly a significant pipeline of automotive activity. It's a little difficult to bifurcate it between traditional applications and the emerging EV applications.
Got it. Thank you.
Our next question comes from the line of John Marchetti with Stifel. Please proceed with your question.
Thanks very much. I'd like to go back just a little bit to the order commentary again. The North American, European, I think is understood to be a little bit more tied to those regions recovering a bit. I'm curious from the China perspective, having those orders get off to a little bit of a slower start and now coming back a little bit, if you can discuss maybe some of the dynamics that are going on there in that market? As we look out into 2021, and I know you're not specifically giving guidance there, but should we expect that the China business may be back more towards the 2019 type of levels? Or do you think something has changed there as we're looking out into 2021?
There's a lot of different aspects to that question there. The order flow in China has been a bit anomalous this year, right? We've had this very, very strong order flow in the first half of the year, and we reiterate we have very strong backlog in China. What's been good to see is that even with that order flow in China and the general tone of the business has been quite positive in September and October. You can't really call it normal just because the backlog is strong, but also the tone generally tends to be a bit more positive at the moment. The feedback we've got from our China business is that Q4, the tone for business remains relatively good. Recent presentations from them for opportunities in 2021 are significant and meaningful.
They're driven by things like EV, the transition to higher power, ultra-high power cutting applications. Within EV, it's battery welding, it's cleaning applications, it's foil cutting. That helps us because of the higher power pulse lasers. There's actually some interesting demand that may come out even of some additive applications in China. There seems to be a broader base potential for the application set in China, and there are a very significant number of opportunities that they're working on. They're even working on looking at displacements of CO2 lasers within traditional automotive industry, where they've identified 1,000 odd CO2 lasers that still potentially could be reduced. If the underlying economics stay relatively strong in China, I think you see that investment cycle continue there.
I will reiterate on the order flow, North America was an extraordinarily strong quarter for us, and the good thing about that was just the diversity of applications. It wasn't materials processing on its own. It was also some of the advanced applications. It was some of the micro materials applications. We actually got another order for medical in October, so that wasn't quite Q3. We called out the strength during the quarter from revenue and bookings on some of the semiconductors applications as well. North America, it was an exceptional quarter for us, and I think it was even a record booking level if you exclude some of the systems businesses.
Thank you.
Our next question is from the line of Nik Todorov with Longbow Research. Pleased to receive their questions.
Yeah, good morning, everyone. I just want to understand, again, going to bookings. You mentioned that China backlog remains very strong several times. Can you help us understand how should we think about seasonality? Obviously, this is not a typical period of the time, as we go into the December and March quarters, typically, the business in China goes down a little bit. How should we think about that relative to the backlog comments and the comments of order pickup in September and October?
We're not going to give any commentary around Q1. It's too early to do that. I think the seasonality in China that's backed into our guidance is fairly in line, even though it is a difficult time to pick that. Revenue in China would be slightly lower, offset by strength in some other regions. China has been giving us good forecasts that they've been tending to get towards the top end of their range, and I think it just depends how the tone of the business holds up there. Beyond that, I think there's an awful lot of commentary I've already given around orders and the tone of the business in these different regions.
Okay.
We introduce
Sorry, Nik, Valentin is going to add.
Now we introduce this quarter some new very exciting product. We also think that they will have very good new chance in China also, not only worldwide. This product very exciting, and now people will pass the test even in China, in a very serious order, volume orders start to grow only in this quarter. We believe that for beginning next year, for us it would be a very serious test to regular product in sales revenue in China and not only China, worldwide.
Okay. Thanks. Just as a follow-up, I think, Tim, can you comment a little bit about the implied fourth quarter gross margin? If my math is correct, it implies about mid-45%. If I look at the revenue, the revenue is about $15 million-$20 million higher than the June quarter where you guys had a 46% margin, and obviously September was very strong, aided by FX. Can you help us understand the implied gross margin and the puts and takes for December?
No, the implied gross margin is very similar actually to Q3. It's 45%-48% at the top end of the range. As you tend towards the top end of the range, you're getting into the upper half of our 45%-50%. I'm assuming for operating expenses, something pretty similar at the top end of the range and slightly lower. I'm not sure whether you're saying 45%. We can come back to that in a bit more detail later. I'm assuming 45%-48%, operating expenses at the top end of the range, similar to Q3. At the bottom end of the range, slightly lower, and then a tax rate of 25%, which would exclude any discrete items that we can't really predict what they would be during the quarter.
Got it. Thanks.
Thank you. As a reminder, to ask a question today, you may press star one. The next question is coming from the line of Michael Feniger with Bank of America. Please proceed with your question.
Hi, guys. Thanks for taking my questions. My first question, just on the high-power lasers, it was flat year-over-year. This was the first quarter that it wasn't down on a year-over-year basis in nine quarters. I'm just hoping, Tim, you could kind of help me understand the impact. If we assume based on your guide for Q4 that high-power lasers are going to potentially accelerate on a year-over-year basis, how do we think about what that does for your mix, since it's been really down for the last nine quarters, and now it seems like it's flat and moving in the right direction?
Yeah, Mike, I think that's a great comment. I think high power was basically flat year-over-year, and given the circumstances, I think that's a pretty interesting observation and a great performance. We benefited from clearly the shift towards ultra-high power that we've called out, where we have significant advantages in terms of just the quality, reliability, electrical efficiency capability of producing that product. Interestingly, the YLR lasers also performed quite well. We called out that they actually grew year-over-year as well. I think that's continuing to demonstrate, again, the overall quality and reliability of the product that we have versus the competition. It shows we're not losing share there. We referenced that we also sold some single mode lasers for advanced applications. That helped a bit with total high power laser sales in the mix there. We've got this very strong backlog for single mode lasers.
We actually took two of the orders taken in the U.S. for 100 kW lasers. That's for applications outside of materials processing. Yeah, I think the performance of that high-power lasers was driven by those factors. I also call out that that's actually, we've got the new ultra-compact U Series in the hands of customers, and they're evaluating it. The performance at the less than four kilowatt range was before significant orders being received for that product. There's potential improvement in 2021 as that product ramps up at the low end of the market.
Makes sense. Tim, I want to ask about your inventories. If you look on a year-over-year basis, your inventories were down year-over-year much more than your revenues. We haven't seen this since 2017. You talked a lot about last year, some of these inventory charges that were taken. You look now, I mean, your inventories are kind of flattish while your sales were accelerating quarter-over-quarter. Can you just give me a frame of reference, how do you feel about your inventories right now? Do you need to increase production to maybe match the demand where your inventories are now and where you think demand might be heading into 2021? Thank you.
I think that's a good operational question. Eugene, what's your view on inventory and the investments and the overall control and execution around that at the moment?
We already mentioned that in 2019, we start to control much more precisely our inventory in different facility. I mean, in Germany, United States, also especially in Russia. During this control, we can improve our position in this key area. I mean, much more control. From this point of view, I think we will continue to check, to control, and to keep our inventory on the exceptional level.
This inventory, our policy in inventory help us to pass this year, very critical year, when this, all the sources, practically, of components and parts supply outside sources have very serious problem and delay, and the average delivery time of new components is so increased. Without inventory create enormous problem in the manufacturing our products. We have now inventory, to pass without any problem this very tough time.
Thank you. Our next question is from the line of Mark Miller with Benchmark Company. Please proceed with your question.
Thank you for your question. Considering a possible change in administration United States and possible impact on tariffs, any thoughts about that in terms of how it might impact IPG if such a thing would occur?
I think, Mark, we can't get into discussing the impact, the outcome of the election. We'll have to see what happens on that. We're a global and international company that operates in multiple end markets. I think for us at the moment, it's more the underlying economic growth that's expected next year globally. GDP is forecast to rebound quite strongly on a global basis. The most interesting and important thing for us would be whether that is actually sustained or whether the pandemic has an impact on that. I think the outcome of the U.S. election is more muted relative to those expectations. I think the other area that we're absolutely focused on is this diversification of the business, the new products at different wavelengths, different pulse durations, addressing different applications. How we execute around those. That, again, is on a global basis.
I don't want to get too hung up on the election results, and I think there's other more, in the near term at least, pertinent things that could impact whether global GDP growth is robust or not next year.
Just as a follow-up, could you estimate what percent of sales are coming from products introduced in the last two years?
The number we give on emerging products, which is not quite the last two years, does include some higher power pulsed lasers, but getting to higher powers on that was 21%. We gave that number in the script.
Thank you.
Thank you. Our next question is coming from the line of Tom Diffely with D.A. Davidson. Please proceed with your questions.
Yeah, good morning. Tim, you mentioned gross margins of 160 basis point improvement year-over-year driven mainly by cost. Does that infer that pricing has been relatively stable for you over that period of time?
On a year-over-year basis, pricing actually still came down. It was more in the 10%-15% range. Some of that is also changes in, sorry, 10%-15% on an average kilowatt basis. In fact, if you looked at high power, average selling prices were down significantly less because of the transition to higher power levels. You've still got competitive dynamics and pricing issues there. Interestingly, if you look at order flow and ASP from the ASP analysis around orders taken in Q3, there were actually slight improvements on that because of some of these ultra-high power lasers and single mode lasers that we booked. Also, the exchange rates have moved a little bit in our favor at the moment, so the renminbi is a bit stronger, the euro is a bit stronger, and that helps with the ASP trends a bit.
The other side of the equation is just it continues to reinforce the ability of the company to reduce costs on product. This is, as I said, even before the new compact YLR-U series introduced, there's certainly some benefit coming from the YLS use. There's also the product mix benefits as you go to ultra-high power lasers, stronger sales of things like green lasers, stronger sales of ultra-high power or higher power nanosecond pulse lasers. These are all areas where we have a competitive advantage and where the value proposition delivered to the customer is exceptionally strong.
Okay, sounds good. On the booking strength, especially in North America, how much of that do you think reflects just some pent-up demand from a couple of quarters of COVID versus matching the true underlying demand level today?
The booking strength in North America is, we referenced that it really came from newer products and newer applications in advance. It wasn't necessarily driven by a rebound on the core materials processing applications. We started to see some more recovery of that, I think probably in September and more recently in October, where we started to see some of the cutting OEMs place some orders. There's a significant order on automotive we're waiting on at the moment. There was an order taken automotive. The real trend on Q3 was from these advanced applications and strength on some of the emerging products in green and UV and ultrafast.
Okay, thanks for your time.
Thank you. The next question is a follow-up from the line of Michael Feniger from Bank of America. Please proceed with your questions.
Hey, guys. Yeah, thanks for squeezing me back in. I'm just curious, Tim, with your cash position where it is, I'm curious, you took this impairment in Genesis. What have you really learned from Genesis? With this cash position, do you think IPG could be moving more aggressively in terms of acquisition to help drive that penetration on welding? How are you guys thinking about that cash position as you head into 2021?
Sure. The cash position and the strength of our balance sheet has been a very significant advantage to the company during the last year, particularly given the volatility in the macroeconomic environment. It leaves us with a tremendous amount of firepower to look at potential acquisitions and investments in new technologies. The learning points on Genesis unfortunately been very impacted by COVID-19, right. There was a lot of growth opportunities in things like aerospace that we were looking at, particularly on the laser-based, and the aerospace industry as everybody knows, is just a complete mess at the moment. It's not that we don't think Genesis is going to be successful. I think that it has just been impacted, and it's going to take a bit of time to get that business to recover.
On the overall acquisition strategy, we continue the successful acquisitions we've done have been around looking at technologies that really fit with our lasers. The acquisition of LDD in Canada is driving significant revenue opportunities given the real-time weld monitoring capability. The acquisition of OptiGrate in Florida really enhances the capability around ultrafast lasers and also even in helping with some of the diode specifications. We're well positioned to look at strong technology acquisitions that benefit the business.
Thank you.
Thank you. At this time, we've reached the end of our question and answer session, and I'll turn the floor back to management for closing remarks.
Thank you for joining us this morning and for your continued interest in IPG. We look forward to speaking with you over the coming weeks, and we'll be participating in a number of virtual investor conferences this quarter. Have a great day, everyone.
Thank you.
Thank you.
Thank you.
This concludes today's conference. You may disconnect your lines at this time. Thank you for your participation.